Guía de laboratorio para el diagnóstico y seguimiento de pacientes con gammapatías monoclonales

Bravo García-Morato, M; Padilla-Merlano, B; Nozal, P; Espiño, M; Juárez, C; Villar, LM; López-Trascas, M.
Rev. clín. esp. (Ed. impr.) ; 216(3): 128-134, abr. 2016. tab, graf
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-150040

Documentos relacionados

  1. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies.
  2. Establishment of reference intervals for free light chains and immunoglobulins in Saudi population.
  3. A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testing.
  4. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
  5. RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance.
  6. Utilizing Mass Spectrometry to Detect and Isotype Monoclonal Proteins in Urine: Comparison to Electrophoretic Methods.
  7. Performance goals for immunoglobulins and serum free light chain measurements in plasma cell dyscrasias can be based on biological variation.
  8. Monoclonal Immunoglobulin Associated with Monoclonal Free Light Chains Invisible on Capillary Electrophoresis.
  9. Heavy and light chains all at once: A new immunofluorescence technique to evaluate monoclonal immunoglobulin deposits.
  10. Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases.